Clinical Trials List
2018-06-01 - 2026-08-31
Phase III
Recruiting1
Terminated10
ICD-10C22
Malignant neoplasm of liver and intrahepatic bile ducts
ICD-10C22.0
Liver cell carcinoma
-
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- 許家豪 Division of General Surgery
- 陳德鴻 Division of General Surgery
- Po-Heng Chuang Digestive System Department
- 楊宏仁 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Pin-Nan Cheng Division of General Internal Medicine
- Chiu Hung Chiu Division of General Internal Medicine
- 簡世杰 Division of General Internal Medicine
- 趙盈瑞 Division of General Surgery
- 周宗慶 Division of General Surgery
- Yih-Jyh Lin Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Yun-Cheng Hsieh Digestive System Department
- Pei-Chang Lee Digestive System Department
- Hao-Jan Lei Division of General Surgery
- Gar-Yang Chau Division of General Surgery
- Shao-Jung Hsu Digestive System Department
The Actual Total Number of Participants Enrolled
13 Completed
Audit
None
Co-Principal Investigator
- SHAO-CIAO LUO Division of General Surgery
- 黃儀倢 Digestive System Department
- 鄭友琦 Division of Radiology
- 張碧倚 Division of Radiology
- 鄭紹彬 Division of General Surgery
- 陳家昌 Digestive System Department
- 呂宜達 Digestive System Department
- Sheng-Shun Yang Digestive System Department
- 葉宏仁 Digestive System Department
- CHUNG-HSIN CHANG Digestive System Department
- 詹以吉 Division of General Surgery
- 蘇德晟 Division of Radiology
- 劉嘯天 Division of General Surgery
- 李少武 Digestive System Department
- 王任卿醫師 Division of Others
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳昭勳 Division of Hematology & Oncology
- 李佩倫 Digestive System Department
- 曹朝榮 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳志州 Digestive System Department
- Shang-Wen Chen Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 董宏達 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 吳昭瑩 Division of General Surgery
- Shih-Jer Hsu Division of General Internal Medicine
- 余健鈞 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳建宏 Digestive System Department
- 張國欽 Division of General Internal Medicine
- 王植熙 Division of General Surgery
- 郭垣宏 Digestive System Department
- 紀廣明 Digestive System Department
- 楊志權 Division of General Surgery
- 許獻文 Division of Radiology
- 顏毅豪 Digestive System Department
- 劉約維 Division of General Surgery
- 李韋鋒 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Kun-Ming Chan Division of Gastroenterological Surgery
- Chen-Chun Lin Digestive System Department
- 周宏學 Division of Gastroenterological Surgery
- 李兆偉 Division of General Surgery
- Ming-Chin Yu Division of General Surgery
- 呂嘉偉 Division of Radiology
- Wei-Chen Lee Division of General Surgery
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
15 Completed
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- 何承懋 Division of General Surgery
- Chien-Hung Chen 未分科
- JA-DER LIANG Digestive System Department
- - - Division of Radiology
- REY-HENG HU Division of General Surgery
- Ying-Chun Shen Division of Hematology & Oncology
- 吳志宏 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Completed
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
84 participants
-
Global
883 participants
